Effects of switching from tenofovir/emtricitabin to abacavir/lamivudine and vice versa on platelet aggregation and coagulation markers in patients with HIV-1 infection
Latest Information Update: 17 Oct 2016
At a glance
- Drugs Emtricitabine/tenofovir (Primary) ; Lamivudine/abacavir (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- Acronyms TAPAS
- 17 Oct 2016 New trial record